Here we propose a genetic DLBCL classifier that integrates the findings of Schmitz–Wright12,13 and Lacy15 and that is based on an optimized panel with a minimal set of markers (26 genes and the BCL2 and BCL6 translocations) that can classify samples individually for the purpose of routine patient management. Here, BCL2 is linked to diffuse large B-cell lymphoma.